Literature DB >> 20503015

Treatment of acute myocardial infarction: beyond process measures to improve outcome.

Franz Eberli.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20503015     DOI： 10.1007/s00508-010-1366-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  15 in total

1.  Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go.

Authors:  Kim A Eagle; Brahmajee K Nallamothu; Rajendra H Mehta; Christopher B Granger; Philippe Gabriel Steg; Frans Van de Werf; Jose López-Sendón; Shaun G Goodman; Ann Quill; Keith A A Fox
Journal:  Eur Heart J       Date:  2008-03       Impact factor: 29.983

2.  [Percutaneous coronary interventions (PCI)].

Authors:  Tassilo Bonzel; Raimund Erbel; Christian W Hamm; Benny Levenson; Franz-Josef Neumann; Hans-Jürgen Rupprecht; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2008-08       Impact factor: 5.460

3.  Quality dimensions of primary percutaneous coronary intervention: timeliness, access, and availability.

Authors:  Farhan J Khawaja; Henry H Ting
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

Review 4.  The quality of care. How can it be assessed?

Authors:  A Donabedian
Journal:  JAMA       Date:  1988 Sep 23-30       Impact factor: 56.272

5.  Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality.

Authors:  Elizabeth H Bradley; Jeph Herrin; Brian Elbel; Robert L McNamara; David J Magid; Brahmajee K Nallamothu; Yongfei Wang; Sharon-Lise T Normand; John A Spertus; Harlan M Krumholz
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

6.  Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction Working Group of the American Heart Association/American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

Authors:  John A Spertus; Martha J Radford; Nathan R Every; Edward F Ellerbeck; Eric D Peterson; Harlan M Krumholz
Journal:  Circulation       Date:  2003-04-01       Impact factor: 29.690

Review 7.  Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.

Authors:  Giuseppe Tarantini; Renato Razzolini; Massimo Napodano; Claudio Bilato; Angelo Ramondo; Sabino Iliceto
Journal:  Eur Heart J       Date:  2009-11-27       Impact factor: 29.983

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

Authors:  Karen P Alexander; L Kristin Newby; Paul W Armstrong; Christopher P Cannon; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan M Krumholz; E Magnus Ohman
Journal:  Circulation       Date:  2007-05-15       Impact factor: 29.690

10.  Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.

Authors:  Petr Widimsky; William Wijns; Jean Fajadet; Mark de Belder; Jiri Knot; Lars Aaberge; George Andrikopoulos; Jose Antonio Baz; Amadeo Betriu; Marc Claeys; Nicholas Danchin; Slaveyko Djambazov; Paul Erne; Juha Hartikainen; Kurt Huber; Petr Kala; Milka Klinceva; Steen Dalby Kristensen; Peter Ludman; Josephina Mauri Ferre; Bela Merkely; Davor Milicic; Joao Morais; Marko Noc; Grzegorz Opolski; Miodrag Ostojic; Dragana Radovanovic; Stefano De Servi; Ulf Stenestrand; Martin Studencan; Marco Tubaro; Zorana Vasiljevic; Franz Weidinger; Adam Witkowski; Uwe Zeymer
Journal:  Eur Heart J       Date:  2009-11-19       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.